ERα degrader 6

Compound 31q is a dual-action small molecule functioning as an ERα degrader (K I = 75 nM) and an aromatase (ARO) inhibitor (IC50 = 37.7 nM) . It demonstrates potent antitumor efficacy in MCF-7 xenograft models, supporting its use in breast cancer research for investigating endocrine resistance mechanisms.